These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 21870889

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Neurodegeneration and neuroprotection in multiple sclerosis].
    Davydovskaia MV, Boĭko AN, Gusev EI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):44-52. PubMed ID: 19891348
    [Abstract] [Full Text] [Related]

  • 26. [Future of non conventional MR techniques in MS].
    Pelletier J, Audoin B, Ranjeva JP.
    Rev Neurol (Paris); 2007 Jun; 163(6-7):663-6. PubMed ID: 17607186
    [Abstract] [Full Text] [Related]

  • 27. New developments in understanding and treating neuroinflammation.
    Infante-Duarte C, Waiczies S, Wuerfel J, Zipp F.
    J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T, Hatzifilippou E, Arnaoutoglou M, Balogiannis S, Koutsouraki E.
    Hell J Nucl Med; 2019 Sep; 22 Suppl 2():113-121. PubMed ID: 31802051
    [Abstract] [Full Text] [Related]

  • 30. Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
    Lambe J, Murphy OC, Saidha S.
    Curr Treat Options Neurol; 2018 Mar 21; 20(4):9. PubMed ID: 29564662
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis.
    Schirmer L, Antel JP, Brück W, Stadelmann C.
    Brain Pathol; 2011 Jul 21; 21(4):428-40. PubMed ID: 21114565
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.